Trials / Terminated
TerminatedNCT00494338
Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer
A Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center controlled, non-comparative open Phase II trial of docetaxel and celecoxib in patients with metastatic androgen independent prostate cancer where efficacy is measured by PSA response defined as a 50% reduction in PSA maintained on two consecutive evaluations at least 4 weeks apart.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Docetaxel |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2005-04-01
- Completion
- 2005-04-01
- First posted
- 2007-06-29
- Last updated
- 2009-10-01
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00494338. Inclusion in this directory is not an endorsement.